TNFSF10 and lymphoma: Ma et al. have shown in a pre-clinical model that rAAV expressing soluble TRAIL can induce apoptosis in liver metastases via hepatic portal vein injection in a mouse xenograft model of lymphoma, suggesting that rAAV–TRAIL may be able to treat liver metastases arising from hematogenous metastasis [42].